Using Expert Witnesses in FCRA Cases - FCRA Focus
JONES DAY PRESENTS® AV 4.0 and the Future of Autonomous Vehicles
On July 28, the FDA approved the country’s first interchangeable biosimilar product. Semglee (insulin glargine-yfgn) is both biosimilar to, and interchangeable with, its reference product Lantus (insulin glargine). Under...more